CAMBRIDGE TRUST CO - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 905 filers reported holding NOVARTIS A G in Q4 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.

Quarter-by-quarter ownership
CAMBRIDGE TRUST CO ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$30,880,998
-0.6%
303,171
-1.5%
1.42%
+1.2%
Q2 2023$31,072,308
+8.8%
307,921
-0.8%
1.41%
+3.2%
Q1 2023$28,567,288
+100549.3%
310,514
-0.8%
1.36%
+7.2%
Q4 2022$28,383
-99.9%
312,864
+8.3%
1.27%
+22.0%
Q3 2022$21,953,000
-10.8%
288,818
-0.8%
1.04%
-3.4%
Q2 2022$24,617,000
+0.5%
291,222
+4.4%
1.08%
+25.6%
Q1 2022$24,488,000
+2.6%
279,064
+2.2%
0.86%
+11.4%
Q4 2021$23,877,000
-50.0%
272,978
-53.3%
0.77%
-20.2%
Q3 2021$47,770,000
+372.1%
584,124
+426.7%
0.96%
+153.3%
Q2 2021$10,118,000
+9.7%
110,893
+2.8%
0.38%
+1.1%
Q1 2021$9,224,000
-7.8%
107,901
+1.9%
0.38%
-20.5%
Q4 2020$9,999,000
+10.9%
105,882
+2.1%
0.47%
+1.9%
Q3 2020$9,017,000
+4.0%
103,689
+0.6%
0.46%
+2.2%
Q2 2020$8,674,000
+4.6%
103,074
+2.4%
0.46%
-20.2%
Q1 2020$8,296,000
-11.5%
100,619
+1.6%
0.57%
+14.9%
Q4 2019$9,377,000
+11.0%
99,022
+1.9%
0.50%
+1.2%
Q3 2019$8,447,000
-4.8%
97,206
+0.0%
0.49%
-4.9%
Q2 2019$8,873,000
-24.6%
97,181
-20.6%
0.52%
-26.7%
Q1 2019$11,761,000
+16.1%
122,328
+3.6%
0.70%
+0.7%
Q4 2018$10,129,000
+8.3%
118,039
+8.7%
0.70%
+29.5%
Q3 2018$9,353,000
+10.1%
108,553
-3.4%
0.54%
+2.3%
Q2 2018$8,492,000
-8.7%
112,418
-2.3%
0.53%
-11.3%
Q1 2018$9,306,000
-1.7%
115,095
+2.1%
0.59%
-0.7%
Q4 2017$9,467,000
-5.1%
112,759
-3.0%
0.60%
-10.6%
Q3 2017$9,976,000
+11.7%
116,206
+8.6%
0.67%
+8.6%
Q2 2017$8,928,000
+118.4%
106,959
+94.4%
0.62%
+127.3%
Q1 2017$4,087,000
-17.1%
55,018
-18.8%
0.27%
-21.9%
Q4 2016$4,932,000
-73.0%
67,716
-70.8%
0.35%
-74.1%
Q3 2016$18,287,000
-0.9%
231,605
+3.5%
1.34%
-5.3%
Q2 2016$18,460,000
+101.6%
223,721
+76.9%
1.41%
+87.9%
Q1 2016$9,159,000
-18.7%
126,432
-3.4%
0.75%
-18.4%
Q4 2015$11,261,000
-8.1%
130,888
-1.8%
0.92%
-14.2%
Q3 2015$12,256,000
+912.1%
133,339
+983.3%
1.07%
+974.0%
Q2 2015$1,211,000
-28.8%
12,309
-28.6%
0.10%
-30.1%
Q1 2015$1,701,000
+3.4%
17,245
-2.8%
0.14%0.0%
Q4 2014$1,645,000
-2.3%
17,746
-0.9%
0.14%
-4.7%
Q3 2014$1,684,000
+3.3%
17,899
-0.6%
0.15%
+6.4%
Q2 2014$1,630,000
+4.0%
18,002
-2.3%
0.14%
-2.1%
Q1 2014$1,567,000
+4.5%
18,422
-1.2%
0.14%
+3.6%
Q4 2013$1,499,000
+4.1%
18,645
-0.7%
0.14%
-2.8%
Q3 2013$1,440,000
+5.8%
18,775
-2.5%
0.14%
+1.4%
Q2 2013$1,361,00019,2550.14%
Other shareholders
NOVARTIS A G shareholders Q4 2016
NameSharesValueWeighting ↓
MANAGED ASSET PORTFOLIOS, LLC 335,936$29,213,0005.81%
Martin Investment Management, LLC 170,759$14,849,0005.36%
Mawer Investment Management Ltd. 8,515,391$740,498,0004.84%
SCHARF INVESTMENTS, LLC 1,212,354$105,426,0004.54%
Hansberger Growth Investors, LP 45,645$3,969,0004.50%
GARLAND CAPITAL MANAGEMENT INC 50,905$4,427,0003.95%
First Fiduciary Investment Counsel, Inc. 193,021$16,785,0003.49%
PROFESSIONAL ADVISORY SERVICES INC 224,087$19,487,0003.48%
WOODLEY FARRA MANION PORTFOLIO MANAGEMENT INC 362,047$31,484,0003.29%
WILKINS INVESTMENT COUNSEL INC 126,470$10,998,0003.28%
View complete list of NOVARTIS A G shareholders